Plasma levels of YKL-40 are elevated, compared to healthy subjects, in patients with different types of cancer, including melanoma [24], [25] and pancreatic carcinoma [26], [27], and is related to stage (highest levels in metastatic disease) and prognosis [9]. Here, CHI3L1 is linked to melanoma.